Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9921275 | European Journal of Pharmacology | 2005 | 6 Pages |
Abstract
Based on the loss of [3H]idazoxan binding in brain homogenates from monoamine oxidase-A and B (MAO-A and MAO-B) deficient mice it has been suggested that imidazoline I2 binding sites are predominantly on MAO. Consistent with this hypothesis the regional distribution of [3H]2-BFI shows some overlap with that previously reported for MAO. However, in the rat imidazoline I2 binding sites have been shown to be heterogeneous in nature and it is likely [3H]2-BFI is binding to multiple imidazoline I2 binding sites within mouse brain.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Nicholas MacInnes, Sheila L. Handley,